New Advanced Therapies course is offered only once this year!
| This week's FierceBiotech is brought to you by Biotech Primer.
Trouble viewing? Click here. |
| Dear E,
It's tough to stay current on the fast-changing field of novel therapies. This brand-new Advanced Therapies class on Nov. 15 in Boston will bring you up-to-date on the latest in innovative drugs currently in development or newly on the market.
In one day, you will learn:
The rationale behind cancer immunotherapies The challenges and second-generation opportunities for immunotherapies The differentiation between the types of DNA- and RNA-based therapies The science driving gene therapy Multiple applications of genome editing Who should attend?
This class is designed for those who work on the "business side" of life sciences so that they can more effectively communicate with those on the "science side." Many attendees work in: business development, finance, legal, marketing, research, quality assurance, regulatory affairs, manufacturing or just need to understand the science of the biopharma industry.
Don't wait - this course is limited to 28 attendees and will not be offered again this year!
|
|
Biotech Primer is trusted by the largest names in the biopharma industry, with more than 75,000 professionals trained since 2001 at companies such as AbbVie, AstraZeneca, Bristol-Myers Squibb and Genentech.
Thank you,
Stacey Hawkins
CEO, Biotech Primer
[email protected]
P.S. If you have multiple employees who could benefit from this training, consider bringing it onsite to your organization. Email me today for a quote. |
|
|
|
| Want to reach 137,000+ FierceBiotech subscribers with your own message?
Contact [email protected] or call 202-824-5074.
About this email: In order to receive FierceBiotech for free, we ask that you accept an occasional email promotion from our sponsors. We carefully screen each promotion and never sell or give away your personal information. If you do not want to receive these messages, you can unsubscribe entirely from FierceBiotech.
Click here to unsubscribe. Refer to our Privacy Policy.
FierceMarkets, a division of Questex, LLC
1900 L St. NW Suite 400
Washington, DC 20036 |
|
